Glyparamide
CAS No. 5581-42-0
Glyparamide( —— )
Catalog No. M33220 CAS No. 5581-42-0
Glyparamide is a hypoglycemic compound that reduces platelet aggregation, resulting in less atherosclerotic plaque formation.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 38 | In Stock |
|
| 5MG | 35 | In Stock |
|
| 10MG | 53 | In Stock |
|
| 25MG | 93 | In Stock |
|
| 50MG | 129 | In Stock |
|
| 100MG | 184 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 456 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGlyparamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionGlyparamide is a hypoglycemic compound that reduces platelet aggregation, resulting in less atherosclerotic plaque formation.
-
DescriptionGlyparamide is an orally active chlorophenyl-containing sulfonylurea. Glyparamide shows hypoglycemic activity and rarely causes hepatic injury.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number5581-42-0
-
Formula Weight353.82
-
Molecular FormulaC15H16ClN3O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 55 mg/mL (155.45 mM; Ultrasonic )
-
SMILESO=C(NC1=CC=C(C=C1)N(C)C)NS(=O)(=O)C2=CC=C(Cl)C=C2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yuntao Liu, et al. Emerging Theranostic Nanomaterials in Diabetes and Its Complications. Adv Sci (Weinh). 2022 Jan;9(3):e2102466.?
molnova catalog
related products
-
Spiraeoside
Spiraeoside (Standard) is the analytical standard of Spiraeoside. This product is intended for research and analytical applications. Spiraeoside, an orally active natural compound, exerts antioxidant activity, inhibits reactive oxygen species (ROS) and malondialdehyde production. Spiraeoside possesses antiallergic, anti-inflammatory and antitumor activities.
-
Oroselone
Oroselone
-
Kobophenol A
Kobophenol A has antimicrobial, and anti-inflammatory activities, it might be a candidate for treatment of inflammatory bone diseases relevant to osteoblast cell death.
Cart
sales@molnova.com